Jean Pierre Garnier
CIK: 0001184175
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 10, 2026BIOA
BioAge Labs, Inc.
Award(A)DirectStock Option (Right to Buy)
22K shares- - Apr 15, 2026CARR
CARRIER GLOBAL Corp
Award(A)DirectDirector DSU
3.3K shares at avg. $58.55- - Jun 5, 2025BIOA
BioAge Labs, Inc.
Award(A)DirectStock Option (Right to Buy)
22K shares- - Apr 9, 2025CARR
CARRIER GLOBAL Corp
Award(A)DirectDirector DSU
3.2K shares at avg. $60.77- - Sep 25, 2024BIOA
BioAge Labs, Inc.
Award(A)DirectStock Option (Right to Buy)
15K shares- - Aug 19, 2024BIOA
BioAge Labs, Inc.
Award(A)DirectStock Option (Right to Buy)
141.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2026 | BIOA BioAge Labs, Inc. | Award(A) Stock Option (Right to Buy) | 22,000 | - | - | Direct |
| Apr 15, 2026 | CARR CARRIER GLOBAL Corp | Award(A) Director DSU | 3,330 | $58.55 | - | Direct |
| Jun 5, 2025 | BIOA BioAge Labs, Inc. | Award(A) Stock Option (Right to Buy) | 22,000 | - | - | Direct |
| Apr 9, 2025 | CARR CARRIER GLOBAL Corp | Award(A) Director DSU | 3,209 | $60.77 | - | Direct |
| Sep 25, 2024 | BIOA BioAge Labs, Inc. | Award(A) Stock Option (Right to Buy) | 15,000 | - | - | Direct |
| Aug 19, 2024 | BIOA BioAge Labs, Inc. | Award(A) Stock Option (Right to Buy) | 141,609 | - | - | Direct |
1-6 of 6 transactions
About GARNIER JEAN PIERRE
GARNIER JEAN PIERRE (SEC CIK 0001184175) files insider reports with the SEC as Director of BioAge Labs, Inc. (BIOA) and Director of CARRIER GLOBAL Corp (CARR).
Signal8 holds 6 ownership filings by GARNIER JEAN PIERRE (1 Form 3, 5 Form 4), filed between Sep 25, 2024 and Jun 12, 2026. Those filings report 6 transactions, from Aug 19, 2024 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on GARNIER JEAN PIERRE's filings is in EMERYVILLE, CA.
Recent filings by GARNIER JEAN PIERRE
- Jun 10, 2026: Grant or award of BIOA derivative securities (Form 4, code A).
- Apr 15, 2026: Grant or award of CARR derivative securities (Form 4, code A).
- Jun 5, 2025: Grant or award of BIOA derivative securities (Form 4, code A).
- Apr 9, 2025: Grant or award of CARR derivative securities (Form 4, code A).
- Sep 25, 2024: Grant or award of BIOA derivative securities (Form 4, code A).
Other insiders filing for BioAge Labs, Inc. (BIOA)
- Barton Shane, Principal Accounting Officer
- Pande Vijay Satyanand, Director
- Hemrajani Rekha, Director
- HEALY JAMES, Director
- ENRIGHT PATRICK G, Director
- Davidson Michael H., Director